These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 20350131)

  • 1. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
    Lesko LJ; Zineh I
    Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug Administration.
    Zineh I; Pacanowski MA
    Pharmacotherapy; 2011 Aug; 31(8):729-35. PubMed ID: 21923598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs, diabetes and pharmacogenomics: the road to personalized therapy.
    Watanabe RM
    Pharmacogenomics; 2011 May; 12(5):699-701. PubMed ID: 21619432
    [No Abstract]   [Full Text] [Related]  

  • 4. One size fits one: pharmacogenetics in gastroenterology.
    Porayette P; Flockhart D; Gupta SK
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system.
    Wong SH; Happy C; Blinka D; Gock S; Jentzen JM; Donald Hon J; Coleman H; Jortani SA; Lucire Y; Morris-Kukoski CL; Neuman MG; Orsulak PJ; Sander T; Wagner MA; Wynn JR; Wu AH; Yeo KT
    Pharmacogenomics; 2010 Jun; 11(6):731-7. PubMed ID: 20504247
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress in pharmacogenomics and its promise for medicine.
    Blake CA; Sobel BE
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future.
    Alfirevic A; Pirmohamed M
    Pharmacogenomics; 2010 Apr; 11(4):497-9. PubMed ID: 20350129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacogenomics].
    Nakatani K; Nobori T
    Rinsho Byori; 2013 Nov; 61(11):1018-25. PubMed ID: 24450107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized medicine and rescuing "unsafe" drugs with pharmacogenomics: a regulatory perspective.
    Avery M
    Food Drug Law J; 2010; 65(1):37-65, i-ii. PubMed ID: 24475534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacogenomics and the path towards personalized medicine].
    Belloso WH; Redal MA
    Medicina (B Aires); 2010; 70(3):265-74. PubMed ID: 20529779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics and active surveillance for serious adverse drug reactions in children.
    Loo TT; Ross CJ; Sistonen J; Visscher H; Madadi P; Koren G; Hayden MR; Carleton BC
    Pharmacogenomics; 2010 Sep; 11(9):1269-85. PubMed ID: 20860467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How pharmacogenomics (PG) are changing practice: implications for prescribers, their patients, and the healthcare system (PG series part I).
    Preskorn SH; Hatt CR
    J Psychiatr Pract; 2013 Mar; 19(2):142-9. PubMed ID: 23507814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics and public health: implementing 'populationalized' medicine.
    Mette L; Mitropoulos K; Vozikis A; Patrinos GP
    Pharmacogenomics; 2012 May; 13(7):803-13. PubMed ID: 22594512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of pharmacogenomics in regulatory science: a product life cycle review.
    Tan-Koi WC; Leow PC; Teo YY
    Pharmacogenomics J; 2018 May; 18(3):359-366. PubMed ID: 29205206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualization of drug therapy: history, present state, and opportunities for the future.
    Lesko LJ; Schmidt S
    Clin Pharmacol Ther; 2012 Oct; 92(4):458-66. PubMed ID: 22948891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biobanking and pharmacogenomics.
    McCarty CA; Wilke RA
    Pharmacogenomics; 2010 May; 11(5):637-41. PubMed ID: 20415552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics: bridging the gap between science and practice.
    Lee KC; Ma JD; Kuo GM
    J Am Pharm Assoc (2003); 2010; 50(1):e1-14; quiz e15-7. PubMed ID: 20368146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicine.
    Frueh FW
    Pharmacogenomics; 2009 Jul; 10(7):1077-81. PubMed ID: 19604080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2013 Dec; 38(6):468-75. PubMed ID: 23895776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.